DYMO PARTNERS WITH GA INTERNATIONAL (LABTAG) TO OFFER CRYOGENIC LABELS FOR DYMO LABELWRITER 5 SERIES PRINTERS
more
Stories about Medizin, Gesundheit
Ancient Viral DNA Shapes Early Embryo Development
Over half of our genomes consists of thousands of remnants of ancient viral DNA, known as transposable elements, which are widespread across the tree of life. Once dismissed as the "dark side" of the genome, researchers at Helmholtz Munich and Ludwig-Maximilians-Universität (LMU) have now revealed their crucial role in early embryo development. Unanswered Questions About the Role of Ancient Viral DNA Transposable ...
moreAsklepios Kliniken GmbH & Co. KGaA
Nomination period for the Broermann Medical Innovation Award started
Gießen (ots) - - Prize money of one million euros higher than the prize money for the Nobel Prize for Medicine - Award honors researchers worldwide who have done pioneering work in medicine, biotechnology, or related fields The nomination period for the Broermann Medical Innovation Award has started. The prize, which will be awarded for the first time this year, is ...
moreAescuvest Capital Partners (ACP) Fund Empowers Visionary Healthtech Innovators for High Returns
Munich (ots/PRNewswire) - Aescuvest Capital Partners (ACP) is at the forefront of Healthtech investing, leveraging its deep expertise in European healthcare innovation to make a global impact. With a focus on companies nearing pivotal MDR and FDA approvals, ACP is not just an investor but a catalyst for transformative change in healthcare. Over the past four years, ACP ...
moreEuropäischer Rechnungshof - European Court of Auditors
EU city-dwellers still suffer from air and noise pollution
moreBAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System
Tel Aviv, Israel (ots/PRNewswire) - The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market BAIBYS™, a pioneering Israeli startup in AI-powered micro-robotics for Artificial Reproductive Technology (ART), today announced it has received the CE mark for its innovative BAIBYS™ system. This milestone enables the company to ...
more
LTS Lohmann Therapie-Systeme AG
LTS wins funding from BARDA’s Patch Forward Prize Competition for two partnerships
moreSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissues
moreBosch Healthcare Solutions GmbH
Vivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergencies
moreGrünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer
morePress Release: STADA sets course for the future - experienced healthcare manager Andreas Fibig to become Chairman of the Board
One documentmoreBIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease
Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...
more
Norgine submits Marketing Authorisation Application to the European Medicines Agency for eflornithine (difluoromethylornithine [DFMO]) in high-risk neuroblastoma
London (ots/PRNewswire) - Back to media releases Next media release Norgine today announced that it completed its marketing authorisation application filing to European Medicines Agency (EMA) for eflornithine in high-risk neuroblastoma (HRNB). This follows the submissions in April 2024, via Project Orbis, in ...
more
25Assessing risks from pharmaceutical residues: How the APRIORA project is helping communities to improve drinking water quality
moreLAUDA DR. R. WOBSER GMBH & CO. KG
Dr. Stefanie Krieger Managing Director of LAUDA Medical
moreLAUDA DR. R. WOBSER GMBH & CO. KG
Antonio Manconi Ten Years With LAUDA Italia
moreRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcers
more- 4
Growth market for exoskeletons: “SUITX by Ottobock” expands world’s largest partner network
more
Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU*
moreMore than half of all young people in the EU feel lonely
Gütersloh (ots) - Many young adults in the EU share the feeling that they are lonely. Around 57 per cent of young Europeans aged from 18 to 35 feel moderately or strongly lonely, according to a new Bertelsmann Stiftung study entitled “Loneliness of Young People Compared across Europe in 2024.” The data for the EU-wide survey derive from the European opinion research tool eupinions. While loneliness among young people ...
moreAccord Healthcare is granted marketing authorisation for IMULDOSA®, ustekinumab biosimilar to Stelara®
London (ots/PRNewswire) - - Accord announces that the European Commission (EC has granted marketing authorisation for Imuldosa® (development code: DMB-3115), a biosimilar to Stelara®, indicated for a range of immune medicated inflammatory diseases. - The EC approval follows a positive opinion issued on 19 October ...
moreMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025
moreTechnische Universität München
Complex pancreatic tumor organoids as foundation for new treatment strategies
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE Foundation for new cancer treatment strategies Organoids represent the complex cell landscape of pancreatic cancer - Tumors are composed of cancer cells with a variety of different characteristics. - This contributes significantly to the complexity of pancreatic cancer and makes the disease difficult to treat. - For the ...
moreObrist Group Introduces Alternatives to PFAS and F-Gases
Obrist Group Introduces Alternatives to PFAS and F-Gases Natural Refrigerants Replacing Harmful Forever Chemicals in Cars Lindau/Germany, Lustenau/Austria – December 10 2024 – Per- and polyfluoroalkyl substances (PFAS) are recognized as highly hazardous, and the European Union is preparing to ban these toxic chemicals. The PFAS group also includes F-gases, such as hydrofluorocarbons, which are widely used in cooling ...
more
Technische Universität München
Removing hazardous PFAS chemicals from drinking water
TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE TUM researchers develop highly effective filter material Removing hazardous PFAS chemicals from drinking water - Metal-organic framework compounds made of zirconium carboxylate as filters - Large-scale use in practice still to come - Contaminated sites caused by PFAS will be with us for several generations ahead The chemicals known as PFAS are considered a severe threat to ...
moreReminder: canSERV Call for Service Provision "Training the Next Generation of Cancer Researchers"
One documentmorePress Release: STADA welcomes Ingo Schachel as Head of Investor Relations
One documentmoreStrides Pharma International AG
Strides Pharma Consolidates European Business-to-Business Operations in Switzerland
moreEuropean Alliance Against Depression
First European Patient Congress Depression for those affected by depression and their close relations takes place online on December 7, 2024 / Free online-event offers information and experience-sharing
Frankfurt am Main (ots) - The European Patient Congress Depression, hosted by the European Alliance Against Depression (EAAD), will take place on December 7, 2024. This free online-event is designed to support individuals affected by depression and their relatives, providing a platform for expert guidance, patient ...
more- 4
IKEA partners with 'SUITX by Ottobock' / 400+ exoskeletons deployed across 14 countries
more
12345678910Next